Literature DB >> 10785483

High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.

Y Aoki1, M Sasaki, M Watanabe, T Sato, I Tsuneki, H Aida, K Tanaka.   

Abstract

OBJECTIVE: The goal of this study was to identify risk factors in patients with node-positive stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy with pelvic lymph node dissection and postoperative irradiation.
METHODS: Two hundred forty-two patients with FIGO stage IB, IIA, and IIB cervical carcinoma underwent radical hysterectomy with pelvic lymph node dissection; pathological analysis of the surgical specimen showed positive lymph nodes in 59 patients. These 59 patients were further treated with postoperative radiotherapy. Eighteen patients were in stage IB, 4 in stage IIA, and 37 in stage IIB. Histological tumor type, tumor size, lymph-vascular space invasion, parametrium infiltration, number of positive nodes, and involvement of common iliac nodes were assessed for correlation with cancer recurrence.
RESULTS: When all these variables were assessed in the Cox proportional regression analysis, parametrium infiltration (P = 0. 0199) and number of positive nodes (two or more nodes) (P = 0.0483) revealed the factor correlating significantly with disease-specific survival. Based on these two factors, node-positive patients could be divided into low-risk (n = 11), intermediate-risk (n = 29), and high-risk (n = 19) groups. The 5-year disease-specific survival for the low-risk group was 100% which was significantly better than the 39.1% for the high-risk group (P = 0.0012).
CONCLUSION: For patients in the high-risk group, it may be worthwhile to consider new strategies to improve survival. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10785483     DOI: 10.1006/gyno.2000.5788

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  33 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy.

Authors:  Mi-Kyung Kim; Jae Weon Kim
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

Review 3.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

4.  ADC Histogram Analysis of Cervical Cancer Aids Detecting Lymphatic Metastases-a Preliminary Study.

Authors:  Stefan Schob; Hans Jonas Meyer; Nikolaos Pazaitis; Dominik Schramm; Kristina Bremicker; Marc Exner; Anne Kathrin Höhn; Nikita Garnov; Alexey Surov
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

5.  Prognostic significance of positive lymph node number in early cervical cancer.

Authors:  Jung-Woo Park; Jong Woon Bae
Journal:  Mol Clin Oncol       Date:  2016-03-30

6.  Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.

Authors:  Nicole D Fleming; Michael Frumovitz; Kathleen M Schmeler; Ricardo dos Reis; Mark F Munsell; Patricia J Eifel; Pamela T Soliman; Alpa M Nick; Shannon N Westin; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2014-11-18       Impact factor: 5.482

Review 7.  Postoperative radiation therapy for carcinoma of the uterine cervix.

Authors:  Takashi Uno; Koichi Isobe; Seiji Yamamoto; Tetsuya Kawata; Hisao Ito
Journal:  Radiat Med       Date:  2006-02

8.  Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer.

Authors:  Yoichi Aoki; Hiroyuki Kanao; Atsushi Fusegi; Makiko Omi; Sanshirou Okamoto; Terumi Tanigawa; Hidetaka Nomura; Kohei Omatsu; Akiko Tonooka
Journal:  Int J Clin Oncol       Date:  2022-06-15       Impact factor: 3.850

9.  Imaging of endometrial and cervical cancer.

Authors:  Shilpa Patel; Sidath H Liyanage; Anju Sahdev; Andrea G Rockall; Rodney H Reznek
Journal:  Insights Imaging       Date:  2010-09-28

Review 10.  Implications of the new FIGO staging and the role of imaging in cervical cancer.

Authors:  Aki Kido; Yuji Nakamoto
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.